1/02/2012

10 High Margin Healthcare Dividend Shares

Perfect Healthcare Dividend Stocks With High Margins by Dividend Yield - Stock, Capital, Investment. I screened stocks from the healthcare sector with a positive dividend yield as well as an operating margin of more than 25 percent. Most of the stocks come from the medical instruments and supplies industry but the highest margin stocks are from the drug, biotechnology and diagnostic industry. 5 stocks from the screening results have a yield of more than 3 percent.

Here are the 3 top dividend stocks sorted by yield:
(Subscribe my Blog via RSS Feed or E-Mail. Alternative, you can follow me on Facebook or Twitter)

PDL BioPharma (NASDAQ: PDLI) has a market capitalization of $866.97 million. The company employs 8 people, generates revenues of $344.98 million and has a net income of $91.87 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $193.52 million. Because of these figures, the EBITDA margin is 56.10 percent (operating margin 56.07 percent and the net profit margin finally 26.63 percent).


The total debt representing 178.77 percent of the company’s assets. Twelve trailing months earnings per share reached a value of $0.74. Last fiscal year, the company paid $1.00 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 8.43, Price/Sales 2.51 and Price/Book ratio is not calculable. Dividend Yield: 9.68 percent. The beta ratio is 0.54.


Long-Term Stock History Chart Of PDL BioPharma Inc. (Click to enlarge)


Long-Term History of Dividends from PDL BioPharma Inc. (NASDAQ: PDLI) (Click to enlarge)


Long-Term Dividend Yield History of PDL BioPharma Inc. (NASDAQ: PDLI) (Click to enlarge)


AstraZeneca (NYSE: AZN) has a market capitalization of $61.13 billion. The company employs 61,100 people, generates revenues of $33,269.00 million and has a net income of $8,081.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $13,380.00 million. Because of these figures, the EBITDA margin is 40.22 percent (operating margin 34.55 percent and the net profit margin finally 24.29 percent).


The total debt representing 16.43 percent of the company’s assets and the total debt in relation to the equity amounts to 39.73 percent. Due to the financial situation, a return on equity of 36.71 percent was realized. Twelve trailing months earnings per share reached a value of $7.29. Last fiscal year, the company paid $2.55 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 6.35, Price/Sales 1.78 and Price/Book ratio 2.81. Dividend Yield: 5.83 percent. The beta ratio is 0.62.


Long-Term Stock History Chart Of AstraZeneca plc (ADR) (Click to enlarge)


Long-Term History of Dividends from AstraZeneca plc (ADR) (NYSE: AZN) (Click to enlarge)


Long-Term Dividend Yield History of AstraZeneca plc (ADR) (NYSE: AZN) (Click to enlarge)


Meridian Bioscience (NASDAQ: VIVO) has a market capitalization of $777.02 million. The company employs 525 people, generates revenues of $159.72 million and has a net income of $26.83 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $45.73 million. Because of these figures, the EBITDA margin is 28.63 percent (operating margin 25.06 percent and the net profit margin finally 16.80 percent).


The total debt representing 0.00 percent of the company’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 19.45 percent was realized. Twelve trailing months earnings per share reached a value of $0.65. Last fiscal year, the company paid $0.76 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 29.03, Price/Sales 4.86 and Price/Book ratio 5.61. Dividend Yield: 4.03 percent. The beta ratio is 0.80.


Long-Term Stock History Chart Of Meridian Bioscience, Inc. (Click to enlarge)


Long-Term History of Dividends from Meridian Bioscience, Inc. (NASDAQ: VIVO) (Click to enlarge)


Long-Term Dividend Yield History of Meridian Bioscience, Inc. (NASDAQ: VIVO) (Click to enlarge)

Here is the full table with some fundamentals (TTM):

10 High Margin Healthcare Dividend Shares (Click to enlarge)

Take a closer look at the full table. The average price to earnings ratio (P/E ratio) amounts to 17.62 while the forward price to earnings ratio is 14.23. The dividend yield has a value of 3.46 percent. Price to book ratio is 4.28 and price to sales ratio 4.17. The operating margin amounts to 37.47 percent.


Related stock ticker symbols:
PDLI, AZN, VIVO, BMY, UTMD, AMGN, TECH, NVO, MLAB, ATRI

Selected Articles:


* I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.

1 comment:

  1. I'm extremely impressed with your writing skills as well as with the layout on your weblog. Is this a paid theme or did you customize it yourself? Anyway keep up the nice quality writing, it’s rare to see a nice blog like this one nowadays..
    online pharmacy no prescription

    ReplyDelete

Do you have any questions or notes to this article?
Please let me know your thoughts and we will discuss it.

If you feel that my work has helped you and you'd like to support my mission to spread investment ideas like honesty, openness, unconditional love, and courage, please make a donation below. I'm very grateful for your support.

Being supported by my readers enables me to give my creative output (articles, pdf free downloads) to the public domain, so it isn't copyrighted. Please share it freely so that others may benefit from it.

Thanks so much for your support. I really appreciate it.

To donate via PayPal, credit card, or e-check, please click the button below:

If you like to receive the Dividend Weekly for free (weekly published E-Book with around 1,000 best dividend paying stocks), please enter your email and verify your adress. Easily unsubscribe at any time.